Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy Questionnaire.

Key Points

• To assess the impact of finerenone on quality of life in heart failure patients using the Kansas City Cardiomyopathy Questionnaire.
• Analysis of component-level outcomes from the Kansas City Cardiomyopathy Questionnaire.
• Utilization of clinical data from the clinical trial NCT04435626.
• Improvements in quality of life scores among heart failure patients on finerenone treatment.
• Clinical relevance established through detailed component-level analyses.